Corifollitropin Alfa: Clinical Trials

37 trials of Corifollitropin Alfa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 4 unknown, 3 terminated, 1 withdrawn. 12 Phase 4, 8 Phase 3, 5 Phase 2, 2 Not applicable, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 7, Unknown 3, Terminated 2
Phase 38Completed 7, Withdrawn 1
Phase 25Completed 4, Terminated 1
Not applicable2Completed 2
Phase 12Completed 2

Follow Corifollitropin Alfa: new trials by email Literature Review of Corifollitropin Alfa trials Research Report on Corifollitropin Alfa

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Continuous Double Ovarian Stimulation.
Corifollitropin Alfa, Follitropin Alfa, Follitropin Alfa Biosimilar - Fertility Issues
Phase 4CompletedInstituto Bernabeu302022-11-172025-05-18
Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial
Corifollitropin alfa, Follitropin Beta - Infertility
Phase 4CompletedIRCCS San Raffaele1102022-02-222024-05-16
The Relationship Between Serum AMH Dynamics and Early or Normal Ovarian Response to Corifollitropin Alfa
Corifollitropin alfa - Infertility, Female
UnknownAzienda Ospedaliero-Universitaria di Modena802020-08-012023-02-08
An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
Follitropin Alfa, Follicle Stimulating Hormone/Luteinizing Hormone - Reproductive Issues, Reproductive Disorder
CompletedIVFarma LLC54842020-01-122021-10-22
Corifollitropin Alpha and Ovarian Response
Corifollitropin Alfa, Menotropins - Infertility, Female
Not applicableCompletedHospital de Clinicas de Porto Alegre3002018-06-152020-06-04
Optimisation of Follicular Recruitment in IVM Cycles
blood sampling, transvaginal ultrasound scanning, oocyte retrieval for IVM - Infertility, Female, Polycystic Ovary Syndrome
Phase 3CompletedUniversitair Ziekenhuis Brussel1452017-11-012023-04-07
Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF
Corifollitropin Alfa - Fertility Disorders
Not applicableCompletedUniversity of Turin, Italy1132017-04-012019-01-25
Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)
Corifollitropin alfa, hCG - Hypogonadotropic Hypogonadism
Phase 3CompletedOrganon and Co172017-02-022024-05-23
Corifollitropin Alfa Versus Follitropin Beta in High Responders
Elonva, Puregon - Infertility
Phase 4UnknownEugonia622015-09-012015-06-22
Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients
corifollitropin alfa, Follitropin Beta - Infertility
Phase 4CompletedVietnam National University4002015-06-012017-08-22
Type of Gonadotropin and Embryo Kinetics of Development
Corifollitropin alfa - Infertility
Phase 4TerminatedIVI Madrid2012015-04-012022-08-11
Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill
Corifollitropin alfa - Oocyte Donation
Phase 4CompletedFundacion Dexeus702015-02-012017-05-16
Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG
low dose hCG, hp-FSH, Corifollitropin Alfa - Infertility
Phase 4CompletedAZ Jan Palfijn Gent1072014-10-012021-02-03
Use of Corifolitropin Alfa in Oocyte Donors
Corifollitropin alfa, Recombinant FSH, HP-hMG - Female Reproductive Problem, Infertility
Phase 4UnknownIVI Madrid3002014-10-012015-07-17
Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders
Corifollitropin alfa - Infertility
Phase 4TerminatedVida Recoletas Sevilla262014-09-012016-01-18
An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)
MK-8962, recFSH, Ganirelix - Infertility
Phase 3WithdrawnOrganon and Co2014-03-012022-02-03
Corifollitropin Alfa Application in PCOS Patients
Corifollitropin alfa - In Vitro Fertilization
Phase 4UnknownShin Kong Wu Ho-Su Memorial Hospital302014-01-012014-08-13
Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial
Corifollitropin alfa, recombinant FSH, Ganirelix - Infertility, Poor Ovarian Response
Phase 3CompletedUniversitair Ziekenhuis Brussel1502013-03-012016-06-23
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
Corifollitropin alfa, hCG - Hypogonadism, Hypogonadotropic Hypogonadism
Phase 3CompletedOrganon and Co182013-02-112024-05-24
Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
Triptorelin, Corifollitropin alfa, hpHMG - Infertility, Poor Ovarian Response
Phase 2CompletedUniversitair Ziekenhuis Brussel512012-07-012013-05-09

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Infertility (20)  ·  Congenital Abnormalities (5)  ·  Infertility, Female (4)  ·  Hypogonadism (2)  ·  Polycystic Ovary Syndrome (2)  ·  Genital Diseases, Female (1)  ·  Helping Behavior (1)  ·  Ovarian Hyperstimulation Syndrome (1)

Sponsors

Organon and Co (17)  ·  Universitair Ziekenhuis Brussel (4)  ·  IVI Madrid (2)  ·  AZ Jan Palfijn Gent (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Azienda Ospedaliero-Universitaria di Modena (1)  ·  Eugonia (1)  ·  Fundacion Dexeus (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  IRCCS San Raffaele (1)  ·  IVFarma LLC (1)  ·  Instituto Bernabeu (1)  ·  National and Kapodistrian University of Athens (1)  ·  Shin Kong Wu Ho-Su Memorial Hospital (1)  ·  University of Turin, Italy (1)

Countries

Belgium (5)  ·  Italy (4)  ·  Spain (4)  ·  Greece (3)  ·  Brazil (2)  ·  Russia (2)  ·  Vietnam (2)  ·  Denmark (1)  ·  Mexico (1)  ·  South Africa (1)  ·  Taiwan (1)

Top investigators

Nikolaos P Polyzos, MD PhD (2)  ·  Antonio La Marca (1)  ·  Antonio Requena, MD, PhD (1)  ·  Dilorom Kamilova, PhD (1)  ·  Efstratios M Kolibianakis, MD, MSc, PhD (1)  ·  Enrico Papaleo, MD (1)  ·  Jiann-Loung Hwang, MD (1)  ·  Juan Carlos Castillo Farfan, MD, PhD (1)  ·  Trifon G Lainas, PhD (1)  ·  Wim Decleer, MD (1)

Results publications

PMID 22587997, PMID 19684043, PMID 26991902, PMID 26950065, PMID 12748128, PMID 15155606, PMID 18684735, PMID 20149360, PMID 20843746, PMID 21622693, PMID 21828117, PMID 21892335, PMID 23352098, PMID 23758821, PMID 24161646, PMID 24813196, PMID 24903202, PMID 25444501, PMID 25492411, PMID 26187300, PMID 27090863, PMID 27619773, PMID 28270212, PMID 28508691, PMID 29040589, PMID 29963011, PMID 30895237, PMID 32185595, PMID 32338123, PMID 38983736

NIH funding

2004 (3), 2015 (1)